Alexamorelin Met 1 is primarily used in research settings to study its effects on growth hormone secretion. It is a growth hormone secretagogue, making it valuable in exploring potential therapeutic applications for conditions related to growth hormone deficiencies. Researchers utilize it to understand its mechanism of action and its potential to stimulate muscle growth, improve recovery, and enhance metabolic functions. Additionally, it is investigated for its possible role in treating age-related decline in growth hormone levels, which can impact muscle mass, bone density, and overall vitality. Its application is largely confined to preclinical studies, focusing on its efficacy and safety profile.